News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy
Lili Yang/LinkedIn
Mar 4, 2025, 05:27

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang, Professor of Microbiology, Immunology and Molecular Genetics at University of California, Los Angeles (UCLA), shared her recent article on LinkedIn:

“January 17, 2025- Our protocol article is published on Nature Protocols, reporting generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture.

Congratulations to all the authors, in particular the co-first authors Yan-Ruide (Charlie) Li, Kuangyi (Coin) Zhou, and Derek Lee!”

Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture

Authors: Yan-Ruide Li, et al.

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

 

allogeneic cancer CAR-NKT cells Derek Lee fight against cancer Global fight against cancer immunology immunotherapy Kuangyi (Coin) Zhou Lili Yang Microbiology Molecular Genetics Nature Protocols OncoDaily Oncology UCLA University of California Yan-Ruide (Charlie) Li
Special Coverage
Blog
Jul 6, 2025, 09:28
Abdu Adem Yesufe: Our First and Highly Anticipated Linear Accelerator (LINAC)
Blog
Jul 6, 2025, 08:26
"Behind Every Empowered Patient is a Dedicated Navigator" Webinar - Pink Africa Foundation
Insight
Jul 6, 2025, 07:47
Samuel Hume: 5 Medical Breakthroughs From June
Blog
Jul 6, 2025, 07:40
Wafik El-Deiry: WIN Consortium in Cancer Personalized Medicine Is Supporting the Tempus AI GEMINI-NSCLC Study
Blog
Jul 6, 2025, 07:09
Olubukola Ayodele: How to Shift from Acute to Community?
Blog
Jul 6, 2025, 02:27
A Public Hearing to Better Meet the Needs of Underserved Communities - European Cancer Organisation
Insight
Jul 5, 2025, 20:31
Diego A. Díaz García: Subclonal Immune Evasion in NSCLC
Blog
Jul 5, 2025, 20:15
Petros Grivas is Receiving 2025 Young Investigator Award
Blog
Jul 5, 2025, 20:00
Roberto Ferrara: Winter of Cancer Immunotherapy is Here
Blog
Jul 5, 2025, 19:42
Mario Balsa: TIME May Not Just Tell the Story - It Could Write the Prognosis STAR-01 at ESMOGI25
Blog
Jul 5, 2025, 19:18
Amol Akhade: CRC Screening Face-Off: Stool vs Blood
Blog
Jul 5, 2025, 18:53
Vivek Subbiah: How Clinical Trials Offer Hope for Those Facing Limited Options